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Poster Session I 97physical and emotional well-being, and many declared that they felt
a beneficial effect from the use of CAM.Conclusions: It is essential
that health professionals explore the use of CAM among their can-
cer patients, educate them about potentially beneficial and proven
therapies in light of the limited available evidence of effectiveness
and potential side effects of CAM.
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PROSPECTIVE MONITORING OF NUTRITIONAL STATUS DURING THE
EARLY PHASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANS-
PLANTATION (HSCT)
Fuji, S.1, Kamiya, S.2, Kim, S.-W.1, Sugiyama, M.2, Fukuda, T.1,
Mori, S.-I.1, Kurosawa, S.1, Yokoyama, H.1, Saito, B.1,
Takahashi, T.1, Heike, Y.1, Tobinai, K.1, Tanosaki, R.1,
Kuwahara, S.2, Takaue, Y.1. 1National Cancer Center Hospital,
Chuo-ku, Tokyo, Japan; 2National Cancer Center Hospital, Chuo-ku,
Tokyo, Japan.
Background: Currently recommended measures of parenteral
nutrition (PN) after HSCT are often associated with hyperglycemia
due to corticosteroids and calcineurin inhibitors, which increases
the risk of infectious complications and mortality. This potential
risk prevents the routine use of PN. In this study, we prospectively
monitored caloric intake, changes in body compartment and bio-
chemical indices, and assessed the correlation between these factors
and clinical outcomes. Methods: Between April 2006 and August
2007, 76 patients received allogeneicHSCT in our institute.We ex-
cluded 16 patients due to progressive disease, graft failure and obvi-
ous fluid retention including engraftment syndrome, heart failure,
renal failure and liver failure. The remaining 60 patients were cate-
gorized according to the mean caloric intake from the beginning of
conditioning to day 56 or discharge: group 1 mean caloric intake
was\ basal energy expenditure (BEE, n 5 17), group 2 1.0–1.3 
BEE (n 5 34), and group 3 . 1.3  BEE (n 5 9). The median
agewas 49.5 years. There were no statistically significant differences
in the proportion of conventional or reduced-intensity conditioning
regimens among the 3 groups. Endpoints were changes in the actual
resting energy expenditure (REE), body weight (BW) and other in-
dicators of body compartments including muscle, fat and water
weight, biochemical indices (total protein, albumin, pre-albumin
and cholinesterase), clinical events including GVHD and infectious
diseases, and length of hospital stay. Results: REE was within the
range 1.0–1.2BEE in all 3 groups. In group 1, BW (7.5%),muscle
(9.1%) and fat (10.8%) were significantly decreased, whereas no sta-
tistically significant loss of BW, muscle and fat was documented in
group 2 or group 3. There was a significant correlation between
weight loss and muscle loss (r5 0.89, P\0.001), but no differences
were found in the biochemical indices, or the incidences of GVHD
and infectious diseases among the 3 groups. The length of the hos-
pital stay after HSCT was significantly longer in group 1 compared
with the other groups (74 vs 55 days, P 5 0.03). Conclusion: Pro-
spective monitoring revealed that low caloric intake was associated
with a significant weight loss, muscle loss and longer length of hos-
pitalization. Our data suggest that the patient’s clinical outcomewill
be improved if the caloric intake during the early phase after alloge-
neic HSCT is maintained over 1.0  BEE.263
CURRENT EPIDEMIOLOGY OF ORAL CANDIDA COLONIZATION IN PA-
TIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGOING HEMATO-
POIETIC STEM CELL TRANSPLANTATION: A LONGITUDINAL,
PROSPECTIVE STUDY
Toro, J.J.1,2, Westbrook, S.D.1,2, Kirkpatrick, W.R.2, Fothergill, A.W.2,
Patterson, T.F.1,2, Redding, S.W.1,2, Freytes, C.O.1,2. 1South Texas Vet-
erans Health Care System, San Antonio, TX; 2University of Texas
Health Science Center at San Antonio, San Antonio, TX.
Background: The epidemiology of yeast colonization and sys-
temic infection in hematopoietic stem cell transplant (HSCT) re-
cipients has changed substantially in recent years. Although
Candida albicans remains the most common yeast pathogen, non-al-
bicans Candida species are increasingly being encountered. The rou-
tine use of fluconazole and its successful use in preventing C.albicans-related colonization and infection have caused a shift to
more resistant yeast species that represent a new clinical challenge.
Objective: To follow the evolution of Candida oral colonization
throughout HSCT therapy, employing fluconazole prophylaxis,
in order to determine the current epidemiology of resistance to
this agent.Methods: In a longitudinal, prospective study we evalu-
ated a total of 55 patients with hematologic malignancies who un-
derwent HSCT (46 autologous and 9 allogeneic) and received
fungal prophylaxis with fluconazole 400 mg PO daily starting the
first day of the conditioning regimen. Samples to assess oralCandida
colonization were collected, using the swish and spit technique,
prior to the start of fluconazole prophylaxis, on transplant day
and on a weekly basis until hospital discharge. Candida species iden-
tification was performed via CHROMagar Candida and germ tube
with confirmation using API-20C. MICs were determined using
CLSI methodology by The University of Texas Health Science
Center at San Antonio Fungus Testing Laboratory. Strain differen-
tiation in selected patients was performed by PCR analysis of each
isolate.Results:Oral colonization byCandida species was identified
in 36 of 55 (65%) patients during the study period (Table 1). Thirty-
two of 36 (89%) of these patients had a positive culture during the
initial evaluation and 26 of 36 (81%) patients had more than one
positive culture despite the use of fluconazole. Seven of 55 (13%)
patients had mixed cultures. Candida species with reduced suscepti-
bility or resistance to fluconazole were seen in 10 of 55 (18%) pa-
tients. Conclusions: Despite fungal prophylaxis with systemic
fluconazole, oral colonization by Candida species remains common
in HSCT recipients. Non-Candida albicans species with decreased
susceptibility to fluconazole continue to emerge. These data suggest
that a longitudinal surveillance with oral sampling, in patients un-
dergoing HSCT, is a good mechanism to identify patients at risk
for systemic infections with fluconazole resistant yeast, and should
be further evaluated.
Table 1. Oral fungal species associated with the HSCT
Yeast Species Total PercentCandida albicans 25 57
Candida glabrata * 12 27
Candida tropicalis 3 7
Candida dubliniensis * 1 2
Candida famata 1 2
Candida krusei * 1 2
Candida parapsilosis 1 2
Saccharomyces cerevisiae 1 2*Of the 10 patients with reduced susceptibility or resistance to flu-
conazole 8 were colonized by C. glabrata, 1 by C. dubliniensis, and 1
byC. krusei . Two of the 8 patients colonized byC. glabratawere col-
onized simultaneously by 2 different strains.264
THE POPSICKLE WITH STRAWBERRY AROMA REDUCES INFUSION-RE-
LATED NAUSEA AND VOMITING DURING THE INFUSION OF CRYOPRE-
SERVED PERIPHERAL BLOOD STEM CELLS
Akgedik, K., Akdogan, S., Aksoy, S., Ozdemir, E. Hacettepe University
Institute of Oncology, Ankara, Turkey.
Background: The aim of this study was to explore the effect of
popsickle with strawberry aroma on the infusion-related toxicity
of cryopreserved autologous peripheral blood stem cells (PBSC).
Methods: We compared two groups of adult patients receiving
popsickle with strawberry aroma during infusion or not to assess
the incidences of adverse events occurring during infusion. All pa-
tients received granisetron 2  3 mg iv, lorezepam 6  1 mg po
for prophylaxis of the nausea and vomiting during conditioning
phase and infusion day. The patients had no evidence of nausea or
vomiting prior to cryopreserved PBSC infusion. The patients
with ongoing nausea or vomiting owing to conditioning regimens
and/or receiving additional anti-emetics were excluded from the
study. Results: Forty-five patients (median age 45, range; 17–75)
were given popsickle with strawberry aroma during infusion and
98 Poster Session I110 (median age, 42, range; 18–75) were not. The two groups were
comparable with respect to age, gender, diagnosis, conditioning
regimens, number of TNCs infused, number of bags infused, total
volume infused, amount of DMSO and infusion rate. Patients re-
ceiving popsickle with strawberry aroma had significantly less nau-
sea (21.8% vs 6.6%, p 5 0.03) and had a trend for less vomiting
(13.6% vs 4.4%, p 5 0.1). Other infusion-related adverse events
were as follows; abdominal cramping, tachycardia, hypertension,
hypotension, chills, fever, sore throat and dyspnea. Incidences of
each of these adverse events were less than 3% in both groups and
were comparable. Conclusions: The use of popsickle with straw-
berry aroma during infusion of cryopreserved autologous PBSCs
significantly decreases infusion-related nausea, decreases vomiting
and recommended in this setting.
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DAPTOMYCIN PLUS CEFEPIME FOR MODERATE AND HIGH-RISK FE-
BRILE NEUTROPENIC PATIENTS WITH INCREASED RISK OF GRAM-POS-
ITIVE INFECTION
Rossetti, J.M., Thatikonda, C., Shadduck, R.K., Sahovic, E.,
Kaplan, R.B., Kennedy, M., Lister, J. Western Pennsylvania Cancer In-
stitute, Pittsburgh, PA.
Introduction: Febrile neutropenia following high dose chemo-
therapy or transplantation generally requires in-patient antimicro-
bial therapy. This vulnerable group of patients often has
indwelling catheters, which increase the risk of certain pathogens.
A focus of infection may not be clear, supporting the use of
a broad-spectrum regimen. As gram-positive bacteria are a leading
cause of infections in febrile neutropenic patients, vancomycin is
commonly used in the initial treatment regimen. The rising inci-
dence of vancomycin-resistance in many transplant units has
prompted the investigation of alternative agents.Methods: A pro-
spective pilot study was conducted utilizing daptomycin (6 mg/kg
IV q 24 hours) and cefepime for moderate to high-risk febrile neu-
tropenic patients with increased risk of gram-positive infections.
Eleven patients (10 male, 1 female) were enrolled, ages 40–82 yrs
(mean 5 58). Four patients were post-hematopoietic stem cell
transplant and 7 patients were post-intensive chemotherapy. The
regimen which resulted in defervescence (temperature\ 38C for
48 hours) was continued until ANC . 500 for 4 consecutive days.
Eight patients (73%) successfully completed empiric therapy, with
6 of them (55%) requiring no regimen alteration and 2 of them
(18%) requiring the addition of a broad empiric antifungal. Of
the 3 remaining patients (27%), 2 developed pneumonia and 1
grew an organism resistant to cefepime. Daptomycin was discontin-
ued in each of these 3 patients with appropriate changes made in
coverage. Results: All patients achieved defervescence with
a mean time to defervescence of 3 days (range 5 1–11 days). The
mean duration to resolution of all signs and symptoms of infection
was 3 days. Average length of hospital stay was 10 days (range5 4–
23). At least 4 patients were able to receive the drug on an out pa-
tient basis, reducing their total hospital stay by 1–3 days. There
were no readmissions due to drug failure in the 1-week follow up pe-
riod. There were no ICU admissions, deaths or treatment-limiting
toxicities. Themost common non-hematological toxicities were hy-
poalbuminemia, high alkaline phosphatase and mild electrolyte ab-
normalities. Conclusion:Daptomycin could be a safe and effective
alternative to vancomycin in the initial regimen for febrile neutro-
penia. Bactericidal activity and activity against many resistant or-
ganisms may reduce duration of fever and associated outcomes.
Once daily dosing may allow outpatient administration.
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USEFULNESS OF BRONCHOSCOPIC LAVAGE IN INTENSIVE CARE UNIT
FOR CRITICALLY ILL STEM CELL TRANSPLANT RECIPIENTS WITH PUL-
MONARY INFILTRATES
Ghosh, S., Finch, C.G., Champlin, R.E., Kebriaei, P., Giralt, S.A.,
Pravinkumar, S.E. The University of Texas MD Anderson Cancer Cen-
ter, Houston, TX.
Background: Acute hypoxemic respiratory failure (AReF) with
pulmonary infiltrates is the most frequent cause for critical care ad-
missions amongst stem cell transplant (SCT) recipients. Pulmonary
infiltrates in cancer patients are nonspecific and can be caused by in-fection, acute lung injury and also by tumor, radiation and chemo-
therapy. Diagnosis of pulmonary infection by chest x-ray has
a sensitivity of 92% but a specificity of only 33%, rendering mico-
biological diagnosis a challenge. We studied the diagnostic yield
and usefulness of bronchoscopic bronchoalveolar lavage (B-BAL)
in critically-ill SCT recipients.Methods: Following IRB approval,
medical records of critically-ill cancer patients admitted to the on-
cological intensive care unit (ICU), with a clinical suspicion of
pneumonia that underwent B-BAL between 5/1/2006 and 10/30/
2006were reviewed retrospectively. Recipients of SCTwith pulmo-
nary infiltrates and AReF were included in this study. B-BAL sam-
ples were obtained from the radiographic sites of infiltrates and sent
for microbiological analysis. Results: During the six-month study
period, 105 critically-ill adult patients underwent B-BAL of which
20 (19%) were SCT recipients. Sixty percent SCT recipients had
lymphoid and 40% myeloid malignancies. Fifteen patients had re-
ceived allogeneic transplants (unrelated 7, haploidentical 5, siblings
2, cord blood 1) and 5 had autologous transplants. The patients
were a median of 119 days post-SCT (range: 6–1189). Only one pa-
tient had received SCT within the prior 3 weeks. Ninety percent of
SCT recipients had radiographic evidence of pulmonary infiltrates
and were mechanically ventilated. Significant microorganisms were
isolated in 63% cases with identification of bacteria 42%, virus 26%
and fungi 21%. The microbiology and related outcomes are shown
in Table 1. Concurrent infections in extra pulmonary sites were
present in 37% of SCT recipients. Respiratory failure was present
in all patients who died.Conclusion: Positive microbiological yield
was obtained by B-BAL in more than half of SCT recipients admit-
ted to ICU with pulmonary infiltrates. AReF with pulmonary infil-
trates is a serious condition in SCT recipients and B-BAL should be
considered as a useful test, early in the management of critically-ill
SCT recipients with pulmonary infiltrates.
B-BAL Microbiological yield & Outcomes in Critically-ill SCT
Recipients
Microorganisms nBacteria
Coagulase Negative Staphylococcus 3
Xanthomonas Maltophilia 2
Enterococcus spp. 2
Klebsiella pneumoniae 1
Legionella spp. 1
Acenitobacter calcoaceticus-baumannii complex 1
Vancomycin Resistant Enterococcus 1Virus
Parainfluenza 2
Adenovirus 2
Cytomegalovirus Antigen 1Fungus
Candida glabarata 2
Mold (Microsporum and Paecilomyces spp.) 2ICU Outcome
Length of stay in days, median (range) 14 (1–32)
Alive 9 (45%)
Dead 11 (55%)Hospital Outcome
Length of stay in days, median (range) 39 (1–84)
Alive 5 (25%)
Dead 15 (75%)267
LARGER STEM CELL DOSE IS ASSOCIATED WITH DECREASED SYMPTOM
SEVERITY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR
MULTIPLE MYELOMA
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Cleeland, C.S.1 1The University of Texas MD Anderson Cancer Center,
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